Internal Medicine, Rheumatology · Dothan, AL
NPI
1285689463
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1118 Ross Clark Cir, Suite 100
Dothan, AL, 36301
Phone (334) 794-1148
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.6M
352,281 services
Medicare patients, 2024
1,453
Average age 74
Drug cost, 2024
$12.2M
6,914 prescriptions
Company payments, 2025
$1,201
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edmund G Lacour was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 77,200 times for 22 patients. In total Edmund G Lacour billed 352,281 services in 109 codes, and Medicare paid $4.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 77,200 | 22 | $3.62 | $279K |
| J3262 Injection, tocilizumab, 1 mg | Office | 68,770 | 15 | $4.72 | $324K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 51,030 | 53 | $8.53 | $435K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 50,210 | 55 | $9.04 | $454K |
| J0897 Injection, denosumab, 1 mg | Office | 37,204 | 378 | $20.16 | $750K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 23,228 | 36 | $33.71 | $783K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 9,428 | 27 | $24.93 | $235K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 9,071 | 129 | $0.10 | $902 |
| J9312 Injection, rituximab, 10 mg | Office | 3,950 | 16 | $61.31 | $242K |
| 96372 Injection Administration | Office | 1,486 | 536 | $9.91 | $15K |
| 85025 Blood Count | Office | 1,464 | 557 | $7.49 | $11K |
| 99214 Office E&M - Established | Office | 1,421 | 727 | $86.10 | $122K |
| 80053 Clinical Chemistry | Office | 1,207 | 531 | $10.18 | $12K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,152 | 25 | $0.23 | $264 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 1,088 | 163 | $0.49 | $529 |
By year: 2022 $4.4M for 313,361 services; 2023 $4.5M for 353,611 services; 2024 $4.6M for 352,281 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,464 | 557 | $7.49 | $11K |
| 80053 Clinical Chemistry | 1,207 | 531 | $10.18 | $12K |
| 81000 Clinical Chemistry | 262 | 158 | $3.86 | $1,013 |
| 80076 Clinical Chemistry | 244 | 159 | $7.90 | $1,927 |
| 82306 Clinical Chemistry | 231 | 224 | $28.51 | $6,585 |
| 82310 Clinical Chemistry | 208 | 180 | $5.04 | $1,047 |
| 84550 Clinical Chemistry | 202 | 105 | $4.41 | $890 |
| 82565 Clinical Chemistry | 172 | 148 | $5.02 | $863 |
| 85652 Clinical Chemistry | 167 | 95 | $2.59 | $433 |
| 86235 Immunoassay | 141 | 21 | $17.57 | $2,478 |
Medicare prescription drug claims, 2024
In 2024, the drug Edmund G Lacour prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 960 prescriptions and refills. In total Edmund G Lacour wrote 6,914 Medicare prescriptions that cost $12.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 960 | 1,524 | 311 | $37K |
| Methotrexate Methotrexate Sodium | 868 | 1,134 | 244 | $14K |
| Prednisone Generic | 388 | 474 | 137 | $2,155 |
| Tramadol Hcl Generic | 278 | 293 | 75 | $4,025 |
| Leflunomide Generic | 269 | 400 | 99 | $16K |
| Prolia Denosumab | 268 | 1,608 | 160 | $462K |
| Humira(Cf) Pen Adalimumab | 225 | 238 | 27 | $2.1M |
| Rinvoq Upadacitinib | 222 | 230 | 32 | $1.5M |
| Enbrel Sureclick Etanercept | 201 | 214 | 28 | $1.6M |
| Allopurinol Generic | 197 | 319 | 67 | $2,063 |
| Alendronate Sodium Generic | 180 | 340 | 60 | $1,485 |
| Sulfasalazine Generic | 164 | 226 | 58 | $3,265 |
| Duloxetine Hcl Generic | 149 | 200 | 33 | $2,379 |
| Tizanidine Hcl Generic | 147 | 161 | 28 | $1,489 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 133 | 133 | 23 | $3,481 |
Brand drugs: - claims; generic drugs: 4,781 claims; opioid claims: 520.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edmund G Lacour $1,201 ($1,201 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $333.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $333 |
| Amgen Inc. AMGN | 17 | $304 |
| UCB, Inc. UCB.BR | 1 | $125 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $125 |
| Radius Health, Inc. | 2 | $122 |
| Medtronic, Inc. MDT | 2 | $64.79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51.12 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $38.81 |
| Smith+Nephew, Inc. SNN | 1 | $21.84 |
| Corcept Therapeutics CORT | 1 | $14.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.